Summary
The purpose of this study was to examine contractile properties of endothelin-1, a newly discovered vasoactive peptide, in guinea pig coronary resistance vessels and abdominal aorta. Changes in perfusion pressure after injections of endothelin-1 were measured using a constant-flow modified Langendorff preparation. The ED10 values of coronary perfusion pressure were about 100-fold less for endothelin-1 than for prostaglandin F2α. After the endothelium was damaged by exposure to free radicals, maximal coronary constriction in response to endothelin-1 (10−9 moles) was not altered, whereas dilator responses to low doses of endothelin-1 were converted to constrictor responses. Removal of the endothelium from aortic rings significantly increased responsiveness to endothelin-1 and the maximal response to the peptide. In calcium-free medium, endothelin-1 induced small increases both in perfusion pressure in coronary vessles and in tension in the aorta. Reintroduction of calcium in the coronary and aortic preparations produced a rapid increase in perfusion pressure and tension, respectively. Further, endothelin-1-induced coronary constriction was inhibited 59%±7% by nifedipine (10−7 moles). We conclude that endothelin-1 is a more potent constrictor than prostaglandin F2α in the coronary vasculature. Endothelin-1-induced constriction in the coronary vasculature of the guinea pig is not mediated through an endogenous constricting factor released from the endothelium or a constrictor prostaglandin. Further, endothelin-1-induced dilation in the coronary vasculature and attenuation of endothelin-1-induced contraction in the abdominal aorta of the guinea pig are mediated through the release of a factor from the endothelium. Endothelin-1-induced coronary constriction and abdominal aortic contraction require extracellular calcium, entering, in part, through nifedipine-sensitive channels.
Similar content being viewed by others
References
Yanagasawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K, Masaki T (1988) A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332: 411–415
Pang DC, Johns A, Patterson K, Parker-Botelho LH, Rubanyi G (1989) Endothelin-1 stimulates phosphatidylinositol hydrolysis calcium uptake in isolated canine coronary arteries. J Cardiovasc Pharmacol 13: S75-S79
Stasch JP, Kazda S (1989) Endothelin-1-induced vascular contractions: interactions with drugs affecting the calcium channel. J Cardiovasc Pharmacol 13: S63-S66
Chabrier PE, Auguet M, Roubert P, Lonchampt MO, Gillard V, Guillon J, Delaflotte S, Braquet P (1989) Vascular mechanism of action of endothelin-1: effect of Ca2+ antagonists. J Cardiovasc Pharmacol 13: S32-S35
Marsden P, Danthuluri NR, Brenner BM, Ballermann B, Brock TA (1989) Endothelin action on vascular smooth muscle involves inositol trisphosphate and calcium mobilization. Biochem Biophys Res Commun 158: 86–93
Watanabe T, Kusumoto K, Kitayoshi T, Shimamoto N (1989) Positive inotropic and vasoconstrictive effects of endothelin-1 in in vivo and in vitro experiments: characteristics and the role of L-type calcium channels. J Cardiovasc Pharmacol 13: S108-S111
Li L, Ishikawa T, Miyauchi T, Yanagasawa M, Kimura S, Goto K, Masaki T (1989) Pressor response to endothelin in guinea pigs. Jpn J Pharmacol 49: 549–552
Sugiura M, Inagami T, Hare GMT, Johns JA (1989) Endothelin action: inhibition by a protein kinase C inhibitor and involvement of phosphoinositols. Biochem Biophys Res Commun 158: 170–176
Van Renterghem C, Vigne P, Barhanin J, Schmid-Alliana A, Frelin C, Lazdunski M (1988) Molecular mechanism of action of the vasoconstrictor peptide endothelin. Biochem Biophys Res Commun 157: 977–985
Wallnofer A, Weir S, Ruegg U, Cauvin C (1989) The mechanism of action of endothelin-1 compared with other agonists in vascular smooth muscle. J Cardiovasc Pharmacol 13: S23-S31
Auguet M, Delaflotte S, Chabrier PE, Pirotzky E, Clostre F, Braquet P (1988) Endothelin and Ca2+ agonist Bay K 8644: different vasoconstrictive properties. Biochem Biophys Res Commun 156: 186–192
Saito A, Shiba R, Kimura S, Yanagasawa M, Goto K, Masaki T (1989) Vasoconstrictor response of large cerebral arteries of cats to endothelin, an endothelium-derived vasoactive peptide. Eur J Pharmacol 162: 353–358
Masaki T (1989) The discovery, the present state, and the future prospects of endothelin. J Cardiovasc Pharmacol 13: S1-S4
Lamb FS, King CM, Harrell K, Burkel W, Webb RC (1987) Free radical-mediated endothelial damage in blood vessels after electrical stimulation. Am J Physiol 21: H1041-H1046
Folta A, Joshua IG, Webb RC (1989) Dilator actions of endothelin in coronary resistance vessels and the abdominal aorta of the guinea pig. Life Sci 45: 2627–2635
de Nucci G, Thomas R, D'Orleans-Juste P, Antunes E, Walder C, Warner T, Vane J (1988) Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium-derived relaxing factor. Proc Natl Acad Sci USA 85: 9797–9800
Rakugi H, Nakamaru M, Tabuchi Y, Nagano M, Mikami H, Ogihara T (1989) Endothelin stimulates the release of prostacyclin from rat mesenteric arteries. Biochem Biophys Res Commun 160: 924–928
Warner T, de Nucci G, Vane J (1989) Rat endothelin is a vasodilator in the isolated perfused mesentery of the rat. Eur J Pharmacol 159: 325–326
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Folta, A., Joshua, I.G. & Webb, R.C. Endothelin-1-induced constriction in the coronary resistance vessels and abdominal aorta of the guinea pig. Heart Vessels 5, 206–211 (1990). https://doi.org/10.1007/BF02058691
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02058691